Liver Cancer Trial, RecruitingNCT04455932Sponsor: Concord Repatriation General HospitalCondition: Liver Cancer
Printed from Voxsanity (voxsanity.com.au) — NCT04455932 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
AI generated eligibility summary.
Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source.
How we use AI
Who might be able to join this trial:
You have been diagnosed with cirrhosis (scarring of the liver) from any common cause, AND your liver is difficult to see clearly on an ultrasound scan.
Your cirrhosis has been confirmed in at least one of these ways: through a liver biopsy, through past serious liver complications (such as fluid in the abdomen, confusion caused by liver disease, swollen veins in the food pipe, or a serious abdominal infection), or through a doctor's clinical suspicion supported by scan findings, a liver stiffness test result above 12.5 kPa, or a low platelet count below 100 with no other explanation.
You have no current or previous diagnosis of liver cancer, confirmed by an ultrasound, CT scan, or MRI within the last 6 months.
You are able to attend scheduled appointments and follow the study plan, in the opinion of the study doctor.
You are willing and able to sign a consent form agreeing to take part.
Who may not be able to join:
You cannot have an MRI scan for any reason, such as having a pacemaker, defibrillator, metal objects in your body, or severe claustrophobia.
You cannot receive the contrast dye (gadolinium) used in some MRI scans.
You are older than 85 years old or younger than 20 years old.
You are currently pregnant or breastfeeding.
You have any other health condition that the study doctor feels would make it unsafe or unsuitable for you to take part (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Principal Investigator: Jessica Yang, MBBS, Concord Repatriation General Hospital
Royal Prince Alfred Hospital, Camperdown, New South Wales
Concord Repatriation General Hospital, Concord, New South Wales
Gosford Hospital, Gosford, New South Wales
Prince of Wales Hospital, Randwick, New South Wales
Westmead Hospital, Westmead, New South Wales
Princess Alexandra Hospital, Brisbane, Queensland
St Vincent's Hospital Melbourne, Fitzroy, Victoria
Austin Hospital, Heidelberg, Victoria
Royal Perth Hospital, Perth, Western Australia
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Voxsanity
Clinical trials and treatments, explained plainly · voxsanity.com.au
Date:
To: My Doctor
Re: Clinical trial enquiry
I am writing to enquire about the following clinical trial which may be relevant to my care:
Trial: NCT04455932
Sponsor: Concord Repatriation General Hospital
Phase: Not Applicable
Status: Recruiting
Condition: Liver Cancer
Trial contact: +61297676495
More information: https://clinicaltrials.gov/study/NCT04455932
Eligibility summary (AI generated)
Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.
Who might be able to join this trial:
You have been diagnosed with cirrhosis (scarring of the liver) from any common cause, AND your liver is difficult to see clearly on an ultrasound scan.
Your cirrhosis has been confirmed in at least one of these ways: through a liver biopsy, through past serious liver complications (such as fluid in the abdomen, confusion caused by liver disease, swollen veins in the food pipe, or a serious abdominal infection), or through a doctor's clinical suspicion supported by scan findings, a liver stiffness test result above 12.5 kPa, or a low platelet count below 100 with no other explanation.
You have no current or previous diagnosis of liver cancer, confirmed by an ultrasound, CT scan, or MRI within the last 6 months.
You are able to attend scheduled appointments and follow the study plan, in the opinion of the study doctor.
You are willing and able to sign a consent form agreeing to take part.
Who may not be able to join:
You cannot have an MRI scan for any reason, such as having a pacemaker, defibrillator, metal objects in your body, or severe claustrophobia.
You cannot receive the contrast dye (gadolinium) used in some MRI scans.
You are older than 85 years old or younger than 20 years old.
You are currently pregnant or breastfeeding.
You have any other health condition that the study doctor feels would make it unsafe or unsuitable for you to take part (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.
This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Concord Repatriation General Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
1 December 2026
Where this trial is recruiting
🇦🇺 Australia
🇳🇿 New Zealand
9 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
HCC detection with US surveillance versus aNC-MRI surveillance
Can't join this trial?
Expanded access pathways
If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.